Subjects have chosen their curative, definitive treatments for prostate cancer prior to enrolling for the study
Subjects are willing to sign the informed consent and agree to comply with the study procedures
You may not be if
Chronic use (\> 2 weeks) of \> 10 mg/day of prednisone or prednisolone within 2 months of the screening (topical or inhalational corticosteroids are permitted)
Concurrent use of immunosuppressive therapy, including: cyclosporine, antithymocyte globulin, or tacrolimus within 3 months of study entry
Other conditions the investigators think may affect subjects' compliance
Clareo Health | Immune Profiles and Circulating Tumor Cell Status Following Prostate Cryotherapy
